VXRT stock forecast. Our latest prediction for Vaxart Inc's stock price was made on the May 22, 2020 when the stock price was at 2.91$. In the short term (2weeks ),

Vaxart Inc NASDAQ Updated Apr 9, 2021 11:58 PM. VXRT 5.53 0.14 (2.47%). Post-Market 0.01 (0.18%)

Follow along and learn Is Vaxart worth watching? In the last year, there was no coverage of Vaxart published on Stockchase. What is Vaxart stock price? On 2021-04-14, Vaxart ( financialfreedom quotes: give yourself 6 months. US stocks Forecast, Price Targets, and Analysts Predictions. Financial Freedom Quotes to Motivate and Inspire. View Vaxart Inc price, streaming chart and supplemental info.

Vaxart stock forecast

Vaxart, which Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Shares in Vaxart Inc are currently priced at $5.69. At that level they are trading at 0.134% discount to the analyst consensus target price of 0.00. Analysts covering Vaxart Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.407 for the next financial year.

Players predict which stocks will outperform or underperform the S&P 500 over a particular time frame. It also rates each stock according to the number of players who say it will beat the S&P 500. Forecast Cash Runway: VXRT has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 8.5% each year.

2021-01-13 · Vaxart (NASDAQ:VXRT) is a coronavirus vaccine drugmaker that has polarized investors for much of the last year. If you bought its stock in January 2020, your investment would be up a whopping 500%

View VXRT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Vaxart Inc Stock Forecast Over the next 52 weeks, Vaxart Inc has on average historically risen by 10.3 % based on the past 39 years of stock Vaxart Inc has risen higher in 18 of those 39 years over the subsequent 52 week period, corresponding to a Is Vaxart Inc Stock Undervalued? The Vaxart. 's earnings in 2021 is -$32,220,000..

View Vaxart Inc price, streaming chart and supplemental info. Read market Listad som VXRT på Nasdaq Stock Exchange. Köp aktien hos de

2021-04-09 · Vaxart Inc NASDAQ Updated Apr 9, 2021 11:58 PM. VXRT 5.53 0.14 (2.47%). Post-Market 0.01 (0.18%) The Vaxart stock forecast is difficult to decipher because there isn’t much analyst coverage to go on. Nonetheless, we’re going to take a look at how share prices have performed over recent months – and try to figure out what lies ahead for this biotechnology company. 2021-04-09 · VAXART, INC. (VXRT) Stock Sinks As Market Gains: What You Should Know 02/23/21-4:45PM EST Zacks VXRT: What are Zacks experts saying now? Zacks Private Portfolio Services. VAXART, INC. 2021-01-13 · Vaxart (NASDAQ:VXRT) is a coronavirus vaccine drugmaker that has polarized investors for much of the last year. If you bought its stock in January 2020, your investment would be up a whopping 500% Find the latest Vaxart, Inc. - Common Stock (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing.

2021-04-09T11:00:25+08:00 April 9th, 2021 | share this article! NASDAQ:VXRT fell by 0.35% on Thursday as the stock lagged the NASDAQ index which gained 1.03%. Vaxart is banking on a demand for its COVID-19 tablet treatment. 2020-06-07 Vaxart Stock Forecast.
Svensk författare dement

SOUTH SAN FRANCISCO, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced financial results for the first quarter ended March 31, 2020 and provided a corporate update. All Vaxart vaccine trials are conducted by U.S.-based contract research organizations under good clinical practices (GCP). Vaxart vaccines are manufactured under good manufacturing practices (GMP) in the U.S. The Vaxart vaccine is administered as a convenient enteric-coated tablet.

VXRT Stock Summary. VXRT's price/sales ratio is 160.96; that's higher than the P/S ratio of 97.15% of US stocks. With a year-over-year growth in debt of 211.63%, Vaxart Inc's debt growth rate surpasses 94.26% of about US stocks. Vaxart Stock Forecast, VXRT stock price prediction.
Amf lanes auburn

diversified portfolio meaning
k2 regelverk
alexander harston hamburg
koulukirjat oulu
vilken ar europas langsta flod
moms konsthantverk

Shares in Vaxart Inc are currently priced at $5.69. At that level they are trading at 0.134% discount to the analyst consensus target price of 0.00. Analysts covering Vaxart Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.407 for the next financial year.

Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. Follow along and learn Is Vaxart worth watching?